BD Diagnostics, a part of Becton Dickinson and Company, announced on Tuesday that the U.S. Food and Drug Administration has cleared the launch of its BD ProbeTec Trichomonas vaginalis Qx Amplified DNA Assay.
The BD ProbeTec Trichomonas vaginalis Qx Amplified DNA Assay will be used in BD Diagnostic’s BD Viper System with XTR Technology to detect T. vaginalis DNA in endocervical, vaginal and urine samples. The BD Viper System is used by laboratories to test samples for T. vaginalis, C. trachomatis and N. gonorrhea and can also be used in batch mode to test for chlamydia and gonorrhea, trichomonas and herpes.